Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00049561.xml
Download PDF
CC BY-NC-ND 4.0 · South Asian J Cancer 2021; 10(01): 03-08
DOI: 10.1055/s-0041-1731909
DOI: 10.1055/s-0041-1731909
Consensus
South Asian Declaration—Consensus Guidelines for COVID-19 Vaccination in Cancer Patients
Authors
Abstract
We provide the South Asian Declaration, containing the consensus guidelines for coronavirus disease 2019 (COVID-19) vaccination in cancer patients.
Publication History
Article published online:
20 August 2021
© 2021. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Thieme Medical and Scientific Publishers Private Ltd
A-12, Second Floor, Sector -2, NOIDA -201301, India
-
References
- 1 Worldometer. COVID-19 coronavirus pandemic. Available at: https://www.worldometers.info/coronavirus/. Accessed April 16, 2021
- 2 Purvish P, Prashant M, Shyam A. Important COVID-19 update—New life-threatening syndrome in pediatric patients?. Int J Mol Immuno Oncol 2020; 5 (02) 42-43
- 3 Parikh PM, Mehta P, Krishna MM, Babu GK. Clinical trials facing serious adverse events during the ongoing COVID-19 pandemic. Indian J Med Paediatr Oncol 2020; 41: 127-131
- 4 Mehta P, Parikh P, Aggarwal S. et al. Has India met this enemy before? From an eternal optimist’s perspective: SARS-CoV-2. Indian J Med Sci 2020; 72: 8-12
- 5 Parikh P, Singh R. Hot race for COVID-19 vaccines - Light at the end of the tunnel just got brighter. Int J Mol Immuno Oncol 2021; 6 (01) 1-3
- 6 World Health Organization. Coronavirus disease (COVID-19): Herd immunity, lockdowns and COVID-19. Available at:https://www.who.int/news-room/q-a-detail/herd-immunity-lockdowns-and-covid-19?gclid=Cj0KCQjwyN-DBhCDARIsAFOELTmy-hL7heEZS3HTnwXonWQwTgsp0j9yvs7ijoG4pdZUP5vp-u_Q4aUaAjwUEALw_wcB#. Accessed on: April 16, 2021
- 7 Chakrabarti SS, Kaur U, Singh A. et al. Of cross-immunity, herd immunity and country-specific plans: experiences from COVID-19 in India. Aging Dis 2020; 11 (06) 1339-1344
- 8 BBC News. England's lockdown to ease as planned on 12 April. Available at: https://www.bbc.com/news/uk-56641596. Accessed on: April 16, 2021
- 9 Chandrashekhar V. Herd immunity? India still has a long way to go, scientists say. Science 2020; 370 (6516) 513
- 10 Banerji A, Wickner PG, Saff R. et al. mRNA vaccines to prevent COVID-19 disease and reported allergic reactions: current evidence and suggested approach. J Allergy Clin Immunol Pract 2021; 9 (04) 1423-1437
- 11 Sokolowska M, Eiwegger T, Ollert M. et al. EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines. Allergy 2021;
- 12 Kaur RJ, Dutta S, Bhardwaj P. et al. Adverse events reported from COVID-19 vaccine trials: a systematic review. Indian J Clin Biochem 2021;
- 13 Available at: https://www.mskcc.org/coronavirus/covid-19-vaccine. Accessed on: April 16, 2021
- 14 American Society of Hematology. Available at: https://www.hematology.org/covid-19/ash- astct-covid-19-and-vaccines
- 15 American Society of Clinical Oncology. Available at:https://www.asco.org/asco-coronavirus- resources/covid-19-patient-care-information/covid-19-vaccine-patients-cancer. Accessed on: April 16, 2021
- 16 Parikh PM, Bapna A, Krishna MV, Mehta P, Aggarwal S, Gulia A. COVID-19 testing in India in comparison to the rest of the world. If Indian testing strategy was replicated in the other top 15 COVID-19 affected countries in the world, the status would be startlingly different. Indian J Med Sci 2020; 72 (02) 107-109
- 17 ESMO Cancer Patient Management During the COVID-19 Pandemic. Available at: https://www.esmo.org/guidelines/cancer-patient-management-during-the-covid-19-pandemic. Accessed April 10, 2021
- 18 Parikh P. COVID-19 pandemic: contrast between SAARC countries and Western World. 2020. Available at: https://www.m3india.in/contents/editor_pick/136721/covid-19-pandemic-contrast-between-saarc. Accessed April 12, 2020
- 19 Tartarone A, Lerose R. COVID-19 and cancer care: what do international guidelines say?. Med Oncol 2020; 37 (09) 80
- 20 Parikh P, Mehta P, Bansal S. et al. Protecting health-care professionals and workers (other than COVID-19 management facilities) from contamination during COVID-19 pandemic. Indian J Med Sci 2020; 72: 3-4
- 21 Miyashita H, Mikami T, Chopra N. et al. Do patients with cancer have a poorer prognosis of online April 21, 2020. COVID-19? An experience in New York City. Ann Oncol 2020; 31 (08) 1088-1089
- 22 Gundavda MK, Gundavda KK. Cancer or COVID-19? A review of guidelines for safe cancer care in the wake of the pandemic. SN Compr Clin Med 2020;
- 23 prpt . Monin-Aldama l, Giang AG, Munoz-Ruiz M, McKenzie DR, del Barro IM, et al. Interim results of the safety and immune-efficacy of 1 versus 2 doses of COVID-19 vaccine BNT162b2 for cancer patients in the context of the UK vaccine priority guidelines. doi:https://doi.org/10.1101/2021.03.17.21253131(MedRxiv) /prpt
- 24 Curigliano G. Cancer patients and risk of mortality for COVID-19. Cancer Cell 2020; 38 (02) 161-163
- 25 Kamboj M, Shah MK. Vaccination of the stem cell transplant recipient and the hematologic malignancy patient. Infect Dis Clin North Am 2019; 33 (02) 593-609
- 26 Hasson F, Keeney S, McKenna H. Research guidelines for the Delphi survey technique. J Adv Nurs 2000; 32 (04) 1008-1015